Search Results 161-170 of 17112 for monoclonal antibody

  1. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Participation eligibility. Participant ...

  2. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

    Combining more than one chemotherapy drug with monoclonal antibody therapy and giving them after surgery may kill any remaining tumor cells. It was not ...

  3. Ovarian Cancer Clinical Trials - Mayo Clinic Research

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. ... Monoclonal antibodies, such as ...

  4. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer - Mayo Clinic

    The purpose of this study is to determine the value of adding AMG 479 (a fully human monoclonal antibody against IGF-1R) to paclitaxel and carboplatin ...

  5. Dr. Yvonne Butler Tobah Archives - Mayo Clinic News Network

    from Dr. Yvonne Butler Tobah, a Mayo Clinic OB-GYN Monoclonal antibody drugs for cancer Monoclonal antibody drugs use […] The post Living With Cancer ...

  6. Ravulizumab-cwvz (intravenous route) - Side effects & uses - Mayo Clinic

    Ravulizumab-cwvz injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...

  7. Rituximab-abbs (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...

  8. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

    Prior chemotherapy, immunotherapy, radioactive, or biological cancer therapy (including monoclonal antibody [mAb]) within 28 days prior to registration.

  9. LS138D, Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may find cancer cells and help kill them. Radioactive substances linked to monoclonal antibodies can bind to ...

  10. How well do you know COVID-19 terminology? - Mayo Clinic News Network

    Monoclonal antibody treatment. Monoclonal antibodies are basically antibodies that will attach to the spike protein of the SARS-CoV-2 virus (the virus that ...